In this work we present evidence that the p53 tumor suppressor protein and NF-κ B transcription factors could be related through common descent from a family of ancestral transcription factors regulating cellular proliferation and apoptosis. P53 is a homotetrameric transcription factor known to interact with the ankyrin protein 53BP2 (a fragment of the ASPP2 protein). NF-κ B is also regulated by ankyrin proteins, the prototype of which is the Iκ B family. The DNA binding sequences of the two transcription factors are similar, sharing 8 out of 10 nucleotides. Interactions between the two proteins, both direct and indirect, have been noted previously and the two proteins play central roles in the control of proliferation and apoptosis.
Background
In this work we present evidence that the p53 tumor suppressor and NF-κ B transcription factors could be related through common descent from a family of ancestral transcription factors regulating cellular proliferation and apoptosis. P53 and related proteins are transcription factors that regulate DNA repair and cellular apoptosis in response to stress and injury, notably those resulting in DNA damage [1] [2] [3] [4] . Although it is a non-essential gene, loss of p53 function in humans through hereditary syndromes is associated with a markedly increased rate of malignancy. Furthermore, over 50% of malignancies have mutated p53 alleles [5] . These observations suggest p53 and related proteins function as a checkpoint for malignant transformation either by repairing DNA damage or by eliminating cells with irreparably damaged DNA [6] [7] [8] P53 is a homotetrameric transcription factor that binds a consensus sequence 5' RRRRC(A/T)(T/A)GYYY-3' (where R indicates purine, A or G; and Y indicates pyrimidine, C or T) [9] . The consensus sequence is usually present as a dimer in p53 inducible gene promoters such as the p21 WAF1 protein regulating cell cycle progression [10] . P53 protein can be divided into three functional domains, the amino-terminal activation domain encompassing amino acids 1-43, the core sequence-specific DNA-binding domain (amino acids 100-300), and the multi-functional carboxy-terminal domain (amino acids 300-393) [11, 12] . Point mutations in p53 identified in malignant cells are clustered around volutionarily conserved regions in the DNA binding region of p53 and simultaneously eliminate both sequence-specific DNA binding and transcriptional activity [12] [13] [14] .
P53 is regulated on multiple levels including post-translationally by modifications such as acetylation, phosphorylation, protein degradation, and protein-protein interaction [15, 16] . Phosphorylation of p53 induces conformational changes that alter interactions with regulatory proteins such as MDM2, which in turn can regulate p53 stability, and can also activate site-specific DNA binding activity [17] [18] [19] [20] [21] [22] . Additional cellular proteins that bind to p53 include proteins of the general transcription machinery such as CBP/p300 [23, 24] . CBP/p300 binding to p53 regulates acetylation and p53 transcriptional activation [25, 26] . P53 is also regulated through association with ankyrin repeat proteins such as p53 binding protein 1 (53 BP1) and p53 binding protein 2 (53BP2, now known to be a fragment of apoptosis stimulating protein of p53 or ASPP2) [27] and gankyrin [28, 29] . Thus, it is likely that p53 is modulated by association with and/or modification by a variety of regulatory proteins including kinases, transcription factors, and ankyrin-containing proteins. In addition, viral proteins also bind to and modify p53 and may contribute to malignant transformation of infected cells by viruses such as papilloma [30, 31] , cytomegalovirus [32] , and Epstein-Barr virus (EBV) [33, 34] .
NF-κ B transcription factors also play a central role in the control of apoptosis [35] [36] [37] . NF-κ B transcription factors bind to the consensus sequence 5'-GGRNNYYCC-3' in the promoters of both cellular and viral genes [38, 39] . The RelA/p65 subunit of NF-κ B is regulated by the ankyrin repeat protein Iκ Bα which masks the nuclear localization signal of the p65/p50 NF-κ B heterodimer [40, 41] . NF-κ Binducing signals are transmitted from the cell surface to the cytoplasm resulting in site-specific phosphorylation at two sites in the N-terminus of Iκ Bα [42] [43] [44] [45] , conjugation of ubiquitin molecules to Iκ Bα , and subsequent degradation of ubiquitinated Iκ Bα by the 26S proteasome complex [46] [47] [48] [49] . Degradation of Iκ Bα in turn unmasks the nuclear localization signal of p50/p65 followed by translocation of the active transcription factor to the nucleus. Other NF-κ B subunits including a homodimer of the p50 subunit also bind Iκ Bα [50] . Iκ Bα deficient animals while viable, die of uncontrolled inflammation in infancy, and mice overexpressing Iκ Bα display an abnormal immunologic repertoire suggesting that a major physiologic role of Iκ Bα is to limit immune and inflammatory responses through a feedback pathway [35, 51, 52] .
Interactions between p53 and NF-κ B have been noted, for example both factors compete for a binding site in the regulatory factor CBP/p300 [53] . Transfection of a constitutively active form of Iκ Bα protein can block p53 dependent cell death [54] [55] [56] and p53 regulatory factors can modulate NF-κ B pathways [57] [58] [59] . Not only are p53 and NF-κ B transcription coregulated under a variety of physiological conditions, but similarity has been noted between the crystal structures of p53 and NF-κ B p50 [14, [60] [61] [62] . Both proteins contain a similarly sited zinc atom that coordinates site specific DNA binding and similar secondary and tertiary organization, but no primary amino acid similarity was noted between the two proteins. Furthermore, p65 has been shown to bind the ankyrin protein p53-binding protein 2 (53BP2). 53BP2 has been shown to be a fragment of a larger protein, ASPP2, that promotes the apoptotis-inducing effects of p53 [27] . P65 apparently inhibits p53-mediated apoptosis by binding to 53BP2/ASSP2 [63] . As with p53, NF-κ B transcription is altered by viral pathogens [64] [65] [66] [67] .
In this work, we present evidence for the specific binding of the NF-κ B inhibitor and ankyrin protein, Iκ Bα , to p53. A physical interaction between p53 and Iκ Bα was also reported by Chang [68] , as well as Zhou, et al. [69] , and was shown to be regulated by proapoptotic and growth suppressing stimuli. Our studies show the binding interaction to involve both ankyrin and non-ankyrin sequences in the Iκ Bα protein, and the DNA binding core domain of p53. We demonstrate that transient expression of Iκ Bα is associated with NF-κ B independent decreases in p53 mediated transcription of a p53 reporter gene in vivo.
These observations were made in Akata cells, an EBVgenome positive lymphoblastoid cell line originally derived from a Burkitts lymphoma. Akata cells lack endogenous functional p53 [33] . We propose that the binding of the ankyrin protein Iκ Bα to p53 is based upon the similarity in molecular structure of NF-κ B and p53.
Results

Similarity between p53 and NF-κ B transcription element binding sites
The hemi-dyad DNA consensus binding sites of p53 and NF-κ B transcription factors are intriguingly similar as has been noted previously by Foo, et al., [70] ; for p53, the binding site sequence is 5'-RRRRC(A/T)(T/A)GYYY-3' and for NF-κ B the binding site sequence is 5'-GGGRNNYYCC-3' where N, R, and Y indicate any nucleotide, purine (A or G), and pyrimidine (C or T), respectively. Two changes in the nucleotide sequence of the C(A/T)(A/T)G core (underscored, above) of a p53 binding site is sufficient to generate the RNNY core (underscored, above) of a NF-κ B binding site while sequences flanking the core are conserved. Depending on the specific sequences, these binding sites potentially encode a hairpin structure that could promote these nucleotide substitutions. Under these circumstances, only one mutagenic event would be necessary, since the second nucleotide exchange could occur by excision-repair following a mutagenic event in the first site. Based on this observation, we hypothesized that both regulatory factors shared descent from a common ancestral transcription factor, a proto-p53/NF-κ B. An alternative possibility is that two independent families of transcription factors, proto-p53 and proto-NF-κ B, converged to independently recognize a similar recognition sequence.
If both p53 and NF-κ B descended from a common ancestral protein, they might retain the ability to bind to common proteins or proteins of related structures in addition to binding similar DNA sequences. With independent descent converging upon a similar DNA binding sequence no such common interactions would be expected. In support of descent from a common ancestral protein, the crystal structure of NF-κ B p65 aligns with that of p53 (Figure 1B and 1D, discussed below) a relationship that would not be expected unless the two proteins were related through phylogeny (descent) as well as ontogeny (function). Furthermore, numerous p53 binding proteins have in common the ankyrin repeat structure, a feature shared with the Iκ B family of NF-κ B regulatory proteins.
Structural alignment of p53 and p65 and ankyrin proteins, 53BP2 and Iκ Bα
To test the hypothesis that p53 and p65 may share structural homology, the known crystal structures of both molecules were aligned using the program C3D4.1 [71] . P53 ( Figure 1A ) has previously been crystallized in association with the ankyrin protein 53BP2 ( Figure 2C ) [28] . Like Iκ Bα (Figure 2A ), 53BP2 is also an ankyrin protein and has been identified as a fragment of a larger protein known as ASPP2 (apoptosis stimulating protein of p53) [27] . The structure of p65 ( Figure 1C ) is taken from the crystal structure of the dimer comprised of p65 and p50 in association with Iκ Bα [50] . P65 has also been crystallized as a homodimer in association with Iκ Bβ [72] .
We used the information content algorithm of C3D4.1 which uses a BLOSUM62 based matrix to calculate conservation between the two pairs of proteins: p53 and p65 ( Figure 1E ); and Iκ Bα and 53BP2 ( Figure 2E ). The amino acids colored red in the aligned structures of 1D and 2D and the amino acid sequences of 1E and 2E depict regions of highest conservation while the grey areas are regions where there is no conservation. As shown by the regions of the two molecules colored red, we observed a surprising degree of structural alignment between the Rel homology domain of p65 and the p53 core domain, supposedly unrelated molecules ( Figure 1D ). The sequence alignment corresponding to the structures in 1D is depicted in 1E.
Using these same methods, we aligned the structures of the ankyrin proteins, Iκ Bα [50] and 53BP2 ( Figure 2D and 2E). The structure used for Iκ Bα (Figure 2A ) contains 71-280 of the wild-type protein. We omitted the SH3 domain of the 53BP2 structure ( Figure 2C ) since it is not relevant to this report. The Iκ Bα protein contains six ankyrin motifs while the 53BP2 contains four. As expected, the two ankyrin proteins show a high degree of alignment. The fourth and 5 th ankyrins of Iκ Bα are in very close alignment to the second and third ankyrins of 53BP2 ( Figure  2D ). The sequences corresponding to these structures is shown in Figure 2E .
Specific binding between Iκ Bα and p53 occurs in vitro
Purified Iκ Bα protein was specifically labelled in vitro with [ 32 P] using p90 rsk which we have previously shown to quantitatively phosphorylate Iκ Bα . [ 32 P] -labeled Iκ Bα was incubated with purified p53 (GST-p53) and precipitated either with glutathione/Sepharose (Seph-GSH) beads to bind the glutathione binding tag on GST-p53 or a p53-specific antibody (Ab2) and protein A/G beads. As shown in Figure 3 , evidence of a specific association between purified bacterially-produced p53 and purified bacterially-produced wild-type Iκ Bα was observed in vitro ( Fig. 2A) . The conformation-specific p53 antibody (Ab5) does not recognize bacterially produced p53
Alignment of p53 (PDB ID:1YCS; 1YCS_A d1) with p65 (PDB ID:1IKN; 1IKN_A d1) Figure 1 Alignment of p53 (PDB ID:1YCS; 1YCS_A d1) with p65 (PDB ID:1IKN; 1IKN_A d1). A. The structures of p53 molecule (taken from the crystal structure of p53 and p53 binding protein 2); B. The aligned structures of p53 and p65; C. The structure of the Rel homology domain of p65 (taken from the crystal structure of the p65/p50 heterodimer bound to Iκ Bα ); D. The aligned structures were colored according to information content based on a BLOSUM62 matrix to calculate conservation using the public domain program CN3D4.1 [70] . A spectrum of red to blue is used to denote the degree of conservation where red is the most conserved. E. The sequence alignment of p53 and p65 is depicted using the same coloring scheme as in the structure alignment in 1D. The structure of 53BP2 (taken from the crystal structure of p53 bound to 53BP2); (D) The aligned structure in 2B colored for conservation according to information content as described above; (E) The sequence alignment of Iκ Bα and 53BP2 is depicted using the same coloring scheme as in the structure alignment in 2D. A four amino acid region near the N-termini of each structure is colored yellow as a reference point. 
D.
P53 and Iκ Bα proteins co-precipitate in vitro. A: Purified bacterially produced Iκ Bα protein co-precipitated specifically with p53 is also shown in lane 5. B: Relatively less ∆ N1 protein than ∆ C1 Iκ Bα protein co-precipitated with GST-p53 from COS cell lysates. After expression of Iκ Bα in COS cells, whole cell lysates were incubated with bacterially produced purified p53 (GST-p53). P53/ Iκ Bα complexes were then precipitated with glutathione Sepharose beads and analyzed by PAGE/Western blotting. In the left panels, ∆ N1 and ∆ A2 proteins were detected using a rabbit polyclonal antisera directed at the C-terminus of Iκ Bα , while in the right panels, ∆ A2 and ∆ C1 proteins were detected using a rabbit polyclonal antisera directed at the N-terminus of Iκ Bα . C: Structures of wild-type Iκ Bα and mutant constructs used in these studies.
(unpublished observations), and Ab5 was used as a control for non-specific association between Iκ Bα and antibody or Protein A/G beads. A c-Jun protein with a glutathione binding protein tag (GST-c-Jun) was used as a control for non-specific association between Iκ Bα and glutathione beads. As shown, no association between control proteins or antibodies was evident.
Relatively decreased in vitro binding between Iκ Bα and p53 results from deletion of the N-terminus of Iκ Bα
Initial experiments conducted with both p53 and Iκ Bα made in bacterial cells supported the hypothesis that the p53 protein could bind to Iκ Bα . Post-translational modifications of the proteins when expressed in eukaryotic cells could affect the interactions noted, particularly with respect to relative binding affinities of mutant proteins. Furthermore, bacterially produced protein may differ in conformation to those produced in mammalian hosts. Overexpression of Iκ Bα alleles in COS cells was used to confirm that binding to p53 was evident with Iκ Bα produced in vivo and also to map the p53 binding to sites within Iκ Bα . Only some alleles of Iκ Bα can be overexpressed in COS cells including Iκ Bα deleted of N-terminal regulatory sequences, denoted ∆ N1(missing amino acids 2-36), ∆ A2 (missing amino acids 110-136), and ∆ C1 deleted of the PEST-containing non-ankyrin C-terminus (amino acids 264-317). A schematic of deletion mutants of Iκ Bα used is depicted in Figure 3C .
After expression of Iκ Bα in COS cells, whole cell lysates were co-precipitated with bacterially produced purified GST-p53 ( Figure 3B) . These experiments confirmed that binding between the proteins was not related to production of an aberrant form of the Iκ Bα protein in bacterial cells since alleles of Iκ Bα protein produced in COS cells were enriched by incubation and co-precipitation with GST-p53. In representative experiments shown, relatively less ∆ N1 protein protein co-precipitated with GST-p53 from COS cell lysates as compared to the proportions of ∆ A2 or ∆ C1 Iκ Bα proteins associating with p53 suggesting that binding between the proteins at least in part required an intact N-terminal region of Iκ Bα . Relative co-precipitation of the C-terminally deleted form of Iκ Bα was comparable to that of wild-type protein (wild-type data not shown), suggesting that the amino acids 264-317 of Iκ Bα was not important for binding to p53.
The binding between Iκ Bα and p53 is disrupted by an antibody to the DNA-binding region of p53
Experiments detailed above confirmed that a specific binding association occurs between Iκ Bα and p53 in vitro. Further experiments were designed to approximate the region on p53 responsible for Iκ Bα binding by use of epitope-specific monoclonal antibodies. Glutathionesepharose beads (G) were used to precipitate p53 ( Figure   4A , lane 1, and 4B, lanes 1 and 5) and were found to coprecipitate Iκ Bα . A monoclonal antibody directed at amino acids 46-55 in the amino terminus of p53 (Ab2) recognized purified bacterially produced p53 (4B, lanes 2 and 6) and also co-precipitated Iκ Bα with p53 (4A, lane 2). In contrast, a different p53-specific monoclonal antibody directed at amino acids 212-217 within the DNA binding core of p53 (Ab3), while able to recognize and precipitate bacterially produced p53 protein (4B, lanes 3 and 7), did not co-precipitate Iκ Ba (4A, lane 4). These observations suggested that the binding site between purified Iκ Bα and p53 in part coincided with the Ab3 epitope, a region which is within the p53 DNA binding core. Alternatively, the antibody could hinder or disrupt Iκ Bα binding to regions near the recognized. epitope or alter the structure of p53 into a conformation unfavorable for Iκ Bα binding.
Overexpression of wild-type Iκ Bα modulates p53 dependent transcription of a synthetic p53 reporter gene in vivo
In vitro studies supported the hypothesis that a direct physical association between p53 and Iκ Bα can occur but they did not provide evidence that such interactions occur in vivo. We hypothesized that transient overexpression of Iκ Bα in cells with co-transfected transcriptionally active p53 might reveal effects of Iκ Bα upon p53 mediated transcription. Using forced overexpression of both proteins from identical viral CMV promoter elements rather than endogenous promoters would eliminate confounding transcriptional effects of Iκ Bα upon transcription of p53 or vice versa. Any effect of NF-κ B upon CMV would be normalized as well.
Akata cells were used because these B-lymphoblastoid cells are known to lack endogenous p53. Neither the wildtype nor a mutant protein is expressed that could complicate interpretation of results. P53 transiently transfected into these cells using dextran sulfate is transcriptionally active. As a control for non-specific effects of transfected plasmid DNA, effects of Iκ Bα expression plasmids were compared to co-transfected plasmid containing an identical CMV promoter element (pCMV). Results shown were also normalized to expression of co-transfected pRL-SV40, a plasmid expressing a second form of luciferase as a control for cell viability and transfection efficiency. We found that wild-type Iκ Bα was associated with decreased p53dependent transcription of the p53 reporter gene pG(13)PyLuc in Akata cells ( Figure 5 6) , and Ab3 (lanes 3,7) , but not Ab5 (lanes 4,8) , as detected with a rabbit polyclonal p53 antiserum. This blot is essentially identical to that shown in panel A but for the antibody used in the Western blotting step. Since Ab5 did not precipitate GST-p53, it served as a negative control for non-specific association between Iκ Bα protein and either antibody or protein A/G beads.
Transient transfection of Iκ Bα alleles specifically blocks p53 transcription in EBV-positive Akata cells Figure 5
Transient transfection of Iκ Bα alleles specifically blocks p53 transcription in EBV-positive Akata cells. A. 200 ng of a p53dependent reporter plasmid encoding 13 copies of the p53 response element driving a firefly luciferase (pG(13)Py/Luc) were cotransfected into 2 × 10 5 cells with 1 ng of an SV40 promoter driven Renilla luciferase (pRLSV40) and 200 ng of a CMV-promoter driven wild-type p53 cDNA construct (wt-p53, denoted below the x-axis) or a C-terminally deleted transcriptionally active p53 (∆ C-p53, denoted below the x-axis). The effect of 800 ng of CMV-promoter driven Iκ Bα alleles or a control construct that did not contain DNA encoding Iκ Bα (to which all data were normalized) were used to determine the effect of Iκ Bα on wild-type p53-mediated transcription of pG(13)Py/Luc while 1600 ng of CMV-promoter driven Iκ Bα alleles (or control) were used in experiments where the ∆ C-p53 allele was used. Immunoblotting controls for wt-p53, ∆ C-p53 and Iκ Bα alleles. B: Western blot analysis of wt-p53 and ∆ C-p53 in the presence of transfected Iκ Bα alleles. Extracts were derived from Akata cells as described for Figure 5A . None indicates transfection of empty CMV vector containing no Iκ Bα allele. C: Western blot analysis for Iκ Bα in the presence of transfected wt-p53. A subset of extracts were analyzed both with C-term and N-term directed Iκ Bα antibodies. Endogenous Iκ Bα is detected by these methods. D: Western blot analysis of Iκ Bα in the presence of ∆ C-p53. ∆ A3 was analyzed on a separate gel due to space limitations and showed a band intensity similar to that of ∆ A4 and ∆ A5 (data not shown).
protein levels for these proteins in these extracts ( Figure  5B-D) .
Allele specific modulation of p53 transcription by Iκ Bα are independent of the effects of the alleles on NF-κ B transcription in vivo
The wild-type Iκ Bα protein is subject to signal-dependent phosphorylation and subsequent degradation leading to release of inhibition of NF-κ B. Deletion (e.g. as in the ∆ N allele deleting amino acids 2-36) or mutation of the phosphorylation sites (S32 and S36) in the amino terminus of Iκ Bα leads to a stable mutant that constitutively represses NF-κ B transcription. Cotransfection at a 1 to 1 ratio of ∆ N1 to p53 expression plasmid (200 ng each of p53 and Iκ Bα plasmid transfected) had no significant effects upon p53 transcription (data not shown). Increasing the relative ratio of ∆ N1 expression plasmid to p53 showed that at higher ratios, ∆ N1 could significantly decrease p53-dependent transcription ( Figure 5A , inhibition of the constitutively active ∆ C-p53 is shown at 1600 ng ∆ N1 plasmid. Similar results were obtained when the ratio of ∆ N1 to wild-type p53 was increased to 8:1, data not shown). However, at the lower ratio of 4:1 shown for the wild-type p53 allele, in Figure 5A , there was little inhibition of transcriptional activity by ∆ N1. The relatively poor inhibitory activity of ∆ N1 towards p53 is consistent with its relatively poor binding affinity for p53 as shown in Figure 3B and described above.
The finding that the ∆ N1 allele is only partially competent to inhibit p53 is consistent with our previous observation that deletion of the N-terminus of Iκ Bα reduced its physical affinity for p53 ( Figure 3 ). While the ∆ N1 allele is a super-repressor of NF-κ B, the ∆ A5 allele does not repress NF-κ B, and thus this allele could be used to ask whether p53 repression and NF-κ B inhibition are separable characteristics of the Iκ Bα molecule. Remarkably, ∆ A5, which cannot repress NF-κ B transcription, had very pronounced inhibitory effects upon transcription by p53 ( Figure 5A ), comparable to that of wild-type.
Mapping of interactions between Iκ Bα and p53 in vivo to the ankyrin 3 domain of Iκ Bα
Ankyrin regions in Iκ Bα , shared with other members of the Iκ B gene family are the sites of binding to NF-κ B transcription factor family members. Further experiments were performed to define the effects of deletion of additional ankyrin domains of Iκ Bα upon p53 transcription in Akata cells. In these experiments, shown in Figure 5 , Iκ Bα plasmids were transfected at 800 ng (at a ratio of 4:1 relative to p53 plasmid). Deletion of either the second (∆ A2, amino acids 110-136, not shown) or fourth ankyrin domains (∆ A4, amino acids 182-208) had the most potent inhibitory effects upon p53 transcription. Deletion of amino acids 264-317 in the carboxyl terminus (∆ C1), distal to the 6 th ankyrin domian, were similarly inhibitory. This region retains the 6 th ankyrin domain but deletes a potentially regulatory acidic PEST region. Deletion of the ankyrin 1 domain of Iκ Bα was not evaluated in this work.
In multiple experiments with wild-type p53, deletion of the ankyrin 3 (∆ A3) domain of Iκ Bα (missing amino acids 143-169) resulted in a loss of inhibitory activity towards p53 transcription. Thus ∆ A3 acts as a null allele for both p53 and NF-κ B transcription in vivo, while other ankyrin deletion alleles of Iκ Bα (∆ A2, ∆ A4, ∆ A5) act as null alleles for NF-κ B but gain of function with respect to p53. Thus, our data are consistent with the hypothesis that the ankyrin 3 and N-terminus of Iκ Bα are cooperatively or independently involved in repressing p53. We cannot, however, rule out an alternative possibility, that the deletion of the ankyrin 3 (∆ A3) of Iκ Bα resulted in a protein with high turnover in Akata cells.
Relative effects of alleles of Iκ Bα are conserved with constitutively active p53 and require transcriptionally active p53
P53 transcription is regulated in part by phosphorylation of the carboxyl terminus of the protein. Phosphorylation induces a conformational change in p53 so that an autoinhibitory region of the carboxyl terminus no longer inhibits DNA binding [73] [74] [75] . To determine whether the effects of Iκ Bα upon p53 transcription required the autoinhibitory carboxyl terminus of p53, experiments were repeated with a truncated form of p53 containing the first 353 amino acids ( Figure 5A , ∆ C-p53) together with an 8fold excess of Iκ Bα plasmid (1600 ng). As expected, these experiments demonstrated increased p53 transcriptional activity measured as p53 -dependent transcription of pG(13)PY/Luc in Akata cells at the same plasmid concentrations compared to experiments using wild-type p53. Co-transfection of a fixed concentration of a plasmid expressing ∆ C-p53 protein (200 ng), and Iκ Bα alleles (1600 ng) demonstrated that the carboxyl terminus of p53 was not required for the association between p53dependent transcription and Iκ Bα expression. As in experiments with wild-type p53, deletion of the ankyrin 4 (∆ A4) domain of Iκ Bα was associated with greater decreases in p53-dependent transcription than other alleles of Iκ Bα . A transcriptionally inactive p53 mutated in the p53 DNA binding core (pC53-CSX3, V193A) gave very low levels of luciferase activity that were not altered by cotransfection of any Iκ Bα alleles (data not shown). Thus, the effects of Iκ Bα upon p53 transcription in Akata cells were found to be entirely dependent upon the presence of co-transfected transcriptionally active p53 but independent of the carboxyl-terminus regulatory sequences of p53.
Allele specific association between Iκ Bα and p53 synthesized in a rabbit reticulocyte lysate (RRL) system correspond to allele specific modulation of transcription in vivo
Some alleles of Iκ Bα including ∆ A3 and ∆ A4 were not stable in COS cells (unpublished observations). Therefore, COS cells could not be used to determine the correlation between Iκ Bα and p53 binding in vitro ( Figure 2B ) and transcriptional effects in Akata cells ( Figure 5 ). Thus, to overcome this technical problem, p53 and Iκ Bα proteins were both separately synthesized in a rabbit reticulocyte lysate system ( Figure 6 ). Iκ Bα synthesized in the reticulocyte lysate system is functionally active in its effects upon NF-κ B transcription factors and ubiquitin-dependent degradation. Likewise, but in contrast to bacterially synthesized p53, p53 synthesized in RRL system is functionally active as a site-specific DNA-binding protein and like Iκ Bα is degraded in vitro by a ubiquitin-dependent pathway. Experiments were performed to determine whether RRL produced p53 that could interact with Iκ Bα alleles likewise translated in vitro in RRL.
Coupled transcription/translation of a plasmid encoding wild-type p53 in RRL (lane 1, Figure 6B ) resulted in several template-specific products that could be precipitated from lysates with p53-specific monoclonal antibodies (lanes 2 and 3, Figure 6B ). These products appeared to be a mixture of full length and less-than full-length p53 proteins resulting from internal initiation sites in the p53 template. Negative control precipitation with IgG2A immunoglobulin (lane 4) or protein G/A beads (lane 5) resulted in undetectable levels of p53 recovery.
Iκ Bα was precipitated with a polyclonal antiserum directed at the Iκ Bα C-terminus in the absence (p53-) or presence of p53 (p53+) protein after both proteins were synthesized in the reticulocyte lysate system ( Figure 6A ). Deletion of the carboxyl terminus of Iκ Bα did not interfere with binding between GST-p53 and Iκ Bα synthesized in COS cells (Figure 2 ), suggesting that binding of antibody directed at the Iκ Bα carboxyl terminus would not interfere with binding between p53 and Iκ Bα . Visual inspection and gel densitometry of these co-precipitation experiments confirmed a specific association between wild-type Iκ Bα and p53. The association of ∆ A3 Iκ Bα allele to p53 was significantly reduced ( Figure 6A, p53+ , lane 3) as determined by gel densitometry (Figure 6D , p < 0.05) relative to the association between the wild-type Iκ Bα , ∆ A4, and ∆ A5 alleles of Iκ Bα to p53. Gel densitometry was not sensitive enough to determine whether small differences in the binding of other Iκ Bα alleles to p53 were significant. In the absence of labeled Iκ Bα , bands corresponding to p53 were still evident (5A, lane 1, p53+) suggesting either non-specific binding or co-precipitation with endogenous unlabeled Iκ Bα . There are small quantities of immuno-detectable Iκ Bα in certain preparations of RRL (L. Ghoda, unpublished observations). Similar results were obtained in experiments in which an antibody against p53 (Ab2) were used to co-precipitate p53 and Iκ Bα alleles (unpublished observations). Binding was also evident between Iκ Bα and p53-related proteins smaller in size than full-length p53 although these interactions could not be reliably quantitated due to variable co-migrating protein species in the relevant portions of the gel.
In vivo binding of ∆ A5-Iκ Bα to wild-type p53
The melanoma cell line A2085 expressing endogenous wild-type p53 was stably transfected with the hemagluttinin (HA)-tagged ∆ A5 allele of Iκ Bα [76] . The ∆ A5 allele was chosen because it has no effect on NF-κ B activity but is one of the more potent alleles of Iκ Bα in modulating p53-dependent transcription. Several independent stable clones as well as pooled transfectants were expanded and used for experiments for which results of the pooled transfectants (DA5) are shown here (Figure 7) . Results were qualitatively similar with pooled vs cells expanded from single colonies. Pooled transformants resulting from antibiotic selection of vector transfected cells were used as controls (Con). Association of ∆ A5-Iκ Bα with p53 was evident when UV-irradiated cell extracts were immunoprecipated using anti-p53 antibody and the immunoprecipitates probed with anti-Iκ Bα antibody (top panel). Likewise, association between transfected Iκ Bα and p53 are evident when immunoprecipitates generated using anti-HA were probed with anti-p53 (bottom row). Immunoprecipitation with normal rabbit serum (ns) precipitated little or no Iκ Bα or p53. Association between endogenous wild-type Iκ Bα and p53 are also evident as seen by the upper band detectable with anti-Iκ Bα western blotting in Con and DA5 lanes when extracts are precipitated with anti-p53. When extracts of irradiated cells are immunoprecipitated with anti-HA, and immunoblotted with anti-Iκ Bα , Both endogenous and ∆ A5 are evident. This is likely due to the precipitation of wt-Iκ Bα with the p53/ ∆ A5-Iκ Bα complex since p53 exists as a tetramer.
Discussion
In this work we determined that Iκ Bα and p53 bind in vitro through a specific interaction in part involving the DNA binding region of p53, or a region proximal to it, and the amino terminus of Iκ Bα independently or cooperatively with the ankyrin 3 domain of Iκ Bα . A physical interaction between p53 and Iκ Bα has been noted by two other groups [68, 69] . Generally, our data corroborate these previously reported interactions and provide further evidence for direct transcriptional modulation of p53 by Iκ Bα . There are some notable differences in our observations from that of others, in particular, the binding site on Iκ Bα was reported as existing in the non-ankyrin C-terminus by Chang [68] in an yeast two-hybrid system using a deletion construct missing amino acids 244-317. This construct in fact deletes the 6 th ankyrin domain of Iκ Bα , located at amino acids 244 -263, retained in our C-termi-nal deletion construct (∆ 264-317) which also retains p53 binding and regulation. When the data are taken in toto, it can be inferred that in fact the 6 th ankyrin domain, and wild-type (lane 6) Iκ Bα proteins were co-incubated with p53, precipitated and analzyed by SDS-PAGE followed by radiography. B. Wild-type p53 protein translated in RRL (lane 1) produced both putative full-length p53 protein (denoted p53, mobility approximately 55 kD) and also at least two less-than-full length translation products (denoted * and **; lanes 1-3). Putative full-length and less-than full-length p53 translation products were precipitated by p53-specific monoclonal antibodies and protein A/G sephadex beads (lane 2, Ab1 recognizing the carboxyl terminus of p53; lane 3, Ab2 recognizing the amino terminus of p53). Less-than full-length proteins were more readily precipitated by Ab1 than Ab2. Control precipitation with IgG2A immunoglobulin (lane 4) or protein G/A beads (lane 5) did not precipitate p53. C. Iκ Bα proteins were precipitated in similar quantities by Iκ Bα antiserum. A shorter exposure of the gel than in panel A is shown. D. Densitometry of p53 protein precipitated in association with various Iκ Bα alleles. Data shows significant precipitation of p53 with ∆ A4, ∆ A5 and wild-type, expressed as a ratio of label precipitating with Iκ Bα allele to beads alone. Data was calculated by first normalizing to the background in each lane followed by calculating the ratio of label precipitating with Iκ Bα to a corresponding area in the beads alone lane.
Rabbit reticulocyte lysate (RRL) produced p53 and Iκ Bα proteins interact in vitro
retained in our construct but deleted in Chang's, may in fact contain another p53 contact point, the loss of which were observed by Chang but not by us.
We also found that deletion of the ankyrin 2, 4, or 5 domains of Iκ Bα increased the inhibitory effect of Iκ Bα on p53-dependent transcription in Akata cells. We speculate that the compacting of the structure by elimination of an ankyrin domain may promote better binding of the protein to p53 as it may convert Iκ Bα to a structure closer in size to that of 53BP2 which only contains four ankyrins. Mutations in the ankyrin regions of Iκ Bα have been characterized regarding their effects upon NF-κ Bmediated transcription as well as nuclear translocation, with most deletions of ankyrins including deletion of ankyrin 5 leading to a null phenotype (confirmed in part in this work in Akata cells) with respect to NF-κ B transcription. Nevertheless, over-expression of ∆ A5-Iκ Bα was more effective than wild-type at decreasing p53 transcrip-tion at all but the lowest concentrations examined. Thus, it was evident that over-expression of some alleles of Iκ Bα could influence p53 transcription independently of their effects upon transcription by NF-κ B. Deletion of the ankyrin 3 region of Iκ Bα eliminated detectable interactions between Iκ Bα and p53 in vivo and in vitro suggesting a critical role of the ankyrin 3 region in a specific in vivo interaction with p53. The combined results obtained using bacterially produced Iκ Bα and p53 ( Figure 2 ) as well as RRL produced proteins ( Figure 6 ) suggest a correlation between in vitro co-precipitation in at least one of the systems and in vivo p53 inhibitory activity. These observations argue for a mechanism involving direct binding of Iκ Bα to p53 in the inhibition of p53 transcriptional activity.
Our interpretation of these observations is that binding between Iκ Bα and p53 occurs primarily between the p53 DNA-binding core or a region proximal to it, and the P53 associates with ∆ A5-Iκ Bα in UV-irradiated melanoma cells [69] where induction of p53 regulatable genes such as p21 and Mdm2 in response to doxorubicin was abrogated by expression of a degradation-resistant form of Iκ Bα . These interactions are strikingly similar to the known interactions between Iκ Bα and its physiologic ligand, NF-κ B. We suggest that these interactions are a result of a conserved relationship, i.e., that of a common descent, of p65 and p53 from a primordial transcription factor which we term proto p53/NF-κ B ( Figure 8B ). Not only do the two transcription factors bind ankyrin proteins but both NF-κ B and p53 have similar DNA binding sites ( Figure 8A ). Furthermore, both factors bind a viral protein encoded by the EBV BZLF-1 open reading frame (also known as ZEBRA) and can transcription can be modulated by this viral protein when overexpressed in lymphoblastoid cell lines [64, 77] . As shown in Figure 8C , we found that a cryptic ankyrin like region is present in the dimerization region of BZLF-1, coincident with the region required for binding to both p65 and p53. With the exception of ankyrin domains, BZLF-1 and Iκ Bα are otherwise not similar in sequence, structure, or function.
Thus, ankyrin repeat domains appear to be key points of interaction between diverse proteins in the NF-κ B and p53 superfamilies. A similar conclusion is suggested by the crystal structure of a complex between p53 and 53BP2 [28] . 53BP2 is a 1002 amino acid protein containing four ankyrin repeats that has been found to be a fragment of an even larger protein known as ASPP2. Residues TYSD located in the 4 th ankyrin repeat of 53BP2/ASPP2 ( Figure  2E , 133 TYsd) binds to the L2 loop of p53 immediately after the zinc ligand site in p53, while the non-ankyrin, SH3 domain of 53BP2 also contribute to the binding interactions. These four residues in 53BP2/ASPP2 are exactly aligned with an equivalent block in the sixth ankyrin repeat of Iκ Bα (Figure 2E , 181 TYqq). It is interesting to note that this corresponds to the 6 th ankyrin domain predicted to be a contact point for p53 as outlined above. Paradoxically, 53BP2/ASPP2 is exclusively cytoplasmic thus it may only inhibit and sequester p53 in the cytoplasm. Iκ Bα thus may fall into a paradigm of endogenous and viral p53 regulatory proteins where ankyrin and non-ankyrin domains contribute to p53 binding and transcriptional modulation. Other ankyrin proteins that bind to either NF-κ B or p53 could also bind and potentially modulate each other.
Conclusion
In conclusion, modulation of p53 transcription by Iκ Bα and related host and viral proteins could play a role in the regulation of p53-dependent apoptosis in vivo. Both p53 and Iκ Bα are members of multi-gene families, and both protein families regulate apoptosis. Previously, a cooperative relationship between p53-dependent apoptosis and NF-κ B activation had been reported [59] . Our observations may represent the converse of this situation where inactivation of NF-κ B (i.e. as a result of elevated Iκ Bα levels) results in inhibition of p53 transcriptional activity. Alternatively, a situation where accumulation of Iκ Bα free of NF-κ B, as a result of phosphorylation of p65 by RSK1 and ensuing dissociation of NF-κ B from Iκ Bα , could result in the regulation of p53 by Iκ Bα [78] . Another setting where our observations may play a significant physiological role is during herpesvirus infection. The Epstein-Barr nuclear antigen (EBNA1) contains a region enriched in gly-ala repeats, and this repeat sequence inhibits the 26S proteasome leading to inhibition of peptide presentation by the MHC Class I restricted pathway [79] . EBNA1 is expressed during viral latency, a condition where it is beneficial for the virus to inhibit apoptosis. Proteasome inhibition will lead to inhibition of all cellular protein degradation and the impact would be the greatest on those proteins with extremely short half-lives such as p53 and Iκ Bα . Thus, the accumulation of Iκ Bα under these circumstances may down regulate the activity of p53.
Decreased p53-dependent transcription could limit the ability of p53 to trigger cellular apoptosis in the presence of inflammation since levels of targets of NF-κ B, including Iκ Bα , are up-regulated. If, in fact, Iκ Bα inhibits or dampens p53 function, cells could continue to proliferate and differentiate in the presence of an inflammatory event even if there is DNA damage or other cellular injury that would normally activate p53-dependent cell cycle arrest and apoptosis. Thus, a combination of inflammation and cellular damage could increase malignant transformation of cells since the threshold for p53 levels to trigger apoptosis may be elevated. It is notable that we know little about what thresholds regulate p53 function -in particular, what determines whether a cell repairs DNA and resumes transit through the cell cycle or dies. A molecule such as Iκ Bα may be involved in influencing thresholddependent cell fate decisions. The observation that truncated p53 proteins may bind to Iκ Bα raises the possibility that short p53-related peptides could alter the binding between Iκ Bα and p53, in turn altering a putative regulatory relationship between these proteins in vivo. Modulation of this regulatory interaction by pharmacologic or other means could potentially alter the balance between cellular proliferation and cell cycle arrest/apoptosis in the context of inflammation.
Methods
In vitro precipitation of p53 and Iκ Bα
Bacterially produced 6xHis-tagged Iκ Bα (His-Iκ Bα ) was labeled in vitro with 32 P using [γ -32 P]ATP and Xenopus laevis p90 rsk (a gift of Dr. James Maller, Howard Hughes Memorial Institute and UCHSC, Denver CO) [80] and detected with polyclonal rabbit antiserum specific to the N-or C-terminus of Iκ Bα as described (a gift of Dr. Warner Greene, the Gladstone Institute for Virology & Immunology, UCSF, San Francisco, CA) GST-p53 produced from a pGEX construct in bacteris was incubated with hexahistidine-tagged Iκ Bα purified as described in [44] in IP buffer buffer containing 25 mM Hepes, pH 7.5, 75 mM KCl, 2.5 mM MgCl 2 , 0.1 mM EDTA, 0.15% NP-40, and 1 mM DTT. Protein complexes were purified using either glutathione conjugated Sepharose beads to bind GST (Pharmacia) for GST-p53 or Protein A/G conjugated Sephadex beads (Oncogene Science, CA). Proteins were separated by polyacrylamide gel electrophoresis (PAGE) on either 10% or 12% gels which were dried and autoradiographed on photographic film (Fuji) for detection of radiolabeled protein or transferred to supported nitrocellulose or PVDF membrane and probed with antibodies using the Renaissance system for western blotting (NEN, Boston, MA). p53 specific monoclonal antibodies Ab1, Ab2, Ab3, Ab5, and Ab6 were obtained from Oncogene Science [81] .
Expression of Iκ Bα alleles in cells
COS cells and Akata cells were transiently transfected using Superfectin (Qiagen, Chatworth, CA) with expression vectors for Iκ Bα alleles in an expression plasmid regulated by a CMV promoter (pCMV5) obtained from Dr. S.C. Sun (Penn State, Hershey, PA). COS cells were lysed in IP buffer (see above) and incubated with p53-pGEX. Overexpression and coprecipitation of Iκ Bα proteins in COS cells was complicated by the apparent instability of some Iκ Bα alleles (∆ A3, ∆ A4) these cells and lack of an association between other alleles (∆ A5) and p53-pGEX (unpublished observations). Following PAGE, ∆ N1 Iκ Bα protein was detected using a rabbit polyclonal antisera directed at the C-terminus of Iκ Bα , while ∆ C1 Iκ Bα protein was detected using a rabbit polyclonal antisera directed at the N-terminus of Iκ Bα in these experiments (antibodies to N-and C-termini of Iκ Bα were a gift of Dr. W.C. Greene, the Gladstone Institute for Virology and Immunology and the University of California, San Francisco, CA).
Transient transfection of Akata cells
Akata cells were obtained from Dr. J. F. Jones (National Jewish Medical Research Center, Denver, CO). The identity of Akata cells was confirmed by expression of EBV lytic gene products following ligation of surface IgG (data not shown). Cells were cultured using standard conditions in RPMI medium (GIBCO-BRL) supplemented with 10% fetal calf serum, penicillin/streptomycin (100 U/ml) and L-glutamine (2 mM). As previously reported, endogenous p53 protein was not detected in Akata cells by Western blotting with a rabbit polyclonal antisera directed at the entire p53 coding sequence (Santa Cruz Biologicals, Santa Cruz, CA) [21, 81] .
Akata cells were transiently transfected with plasmids using dextran sulfate (Pharmacia). p53 protein transiently expressed by plasmids transfected into Akata cells could be detected in nuclear extracts of transfected cells (data not shown). Levels of transfected wild-type Iκ Bα protein were not detected by Western blotting above a high background of endogenous Iκ Bα proteins in Akata cells, although expression of Iκ Bα protein could be inferred by effects on transcription of NF-κ B reporter genes. Akata were grown to a density of 1 × 10 6 cells/ml and 1 ml of cells for each experiment were transfected with Dextran. After transfection, cells were incubated in fresh culture medium for 24 hours prior to determination of luciferase activity.
Luciferase assay
A luciferase reporter gene regulated by 13 tandem copies of a p53 response element, denoted pG(13)PyLuc, or p21 promoter reporter, denoted WWP/Luc, were transfected into Akata cells in experiments at concentrations indicated. As noted in the text the relative effects of different alleles of Iκ Bα upon p53 dependent luciferase expression varied with the relative ratios of expression vector for Iκ Bα to expression vector for p53. CMV-promoter driven p53 expression plasmids encoding wild-type p53 (pC53-SN3) and a DNA binding mutated p53 (pC53-CSX3 V193A) were obtained from Dr. B. Vogelstein, (Johns Hopkins University, Baltimore, MD). An expression plasmid encoding a carboxyl-terminus deleted p53 (pCEP4-353) was obtained from Dr. J. Pietenpol, Vanderbilt Univ., Memphis, TN). Plasmids were prepared using either the Promega (Madison, WI) or Qiagen (Chatsworth, CA) procedures with similar results.
A plasmid encoding a second form of luciferase (Renilla luciferase) driven by an SV40 promoter was used as an internal control for transfection efficiency and cell viability (pRL-SV40, Promega, Madison WI). Similar results were obtained without pRL transfection by normalization of luciferase activity to total cellular protein. Luciferase activity was measured using the Stop and Glo assay (Promega) and an Analytical Luminescence Laboratory luminometer (San Diego, CA). Each data point shown from luciferase assay experiments represents pooled data from at least three independent experiments. Standard error and significant differences (p < 0.05, indicated with an asterick, *) were as determined by the students t-test for multiple comparisons of data points using statistical software (SAS Institute Inc, Cary, NC).
